These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16895581)

  • 1. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis.
    Petri S; Kiaei M; Damiano M; Hiller A; Wille E; Manfredi G; Calingasan NY; Szeto HH; Beal MF
    J Neurochem; 2006 Aug; 98(4):1141-8. PubMed ID: 16895581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rosmarinic acid in motor dysfunction and life span in a mouse model of familial amyotrophic lateral sclerosis.
    Shimojo Y; Kosaka K; Noda Y; Shimizu T; Shirasawa T
    J Neurosci Res; 2010 Mar; 88(4):896-904. PubMed ID: 19798750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron porphyrin treatment extends survival in a transgenic animal model of amyotrophic lateral sclerosis.
    Wu AS; Kiaei M; Aguirre N; Crow JP; Calingasan NY; Browne SE; Beal MF
    J Neurochem; 2003 Apr; 85(1):142-50. PubMed ID: 12641736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.
    Chi L; Ke Y; Luo C; Gozal D; Liu R
    Neuroscience; 2007 Feb; 144(3):991-1003. PubMed ID: 17150307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.
    Kiaei M; Kipiani K; Chen J; Calingasan NY; Beal MF
    Exp Neurol; 2005 Feb; 191(2):331-6. PubMed ID: 15649489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model.
    Wang R; Zhang D
    Eur J Neurosci; 2005 Nov; 22(9):2376-80. PubMed ID: 16262676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate slows disease progression in a G93A SOD1 mutant transgenic mouse model.
    Park JH; Hong YH; Kim HJ; Kim SM; Kim MJ; Park KS; Sung JJ; Lee KW
    Neurosci Lett; 2007 Feb; 413(3):265-9. PubMed ID: 17174029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection method of the adjacent motor neuronal death in an in vitro co-culture model of familial ALS-associated Cu/Zn superoxide dismutase.
    Park KS; Kim HJ; Choi WJ; Kim M; Lee KW
    Biotechnol Lett; 2004 Aug; 26(15):1201-5. PubMed ID: 15289674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-permeable AMPA receptors promote misfolding of mutant SOD1 protein and development of amyotrophic lateral sclerosis in a transgenic mouse model.
    Tateno M; Sadakata H; Tanaka M; Itohara S; Shin RM; Miura M; Masuda M; Aosaki T; Urushitani M; Misawa H; Takahashi R
    Hum Mol Genet; 2004 Oct; 13(19):2183-96. PubMed ID: 15294873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in a transgenic model of familial ALS.
    Hall ED; Andrus PK; Oostveen JA; Fleck TJ; Gurney ME
    J Neurosci Res; 1998 Jul; 53(1):66-77. PubMed ID: 9670993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of activity-dependent neurotrophic factor against toxicity from familial amyotrophic lateral sclerosis-linked mutant SOD1 in vitro and in vivo.
    Chiba T; Hashimoto Y; Tajima H; Yamada M; Kato R; Niikura T; Terashita K; Schulman H; Aiso S; Kita Y; Matsuoka M; Nishimoto I
    J Neurosci Res; 2004 Nov; 78(4):542-52. PubMed ID: 15478191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis.
    Petri S; Kiaei M; Kipiani K; Chen J; Calingasan NY; Crow JP; Beal MF
    Neurobiol Dis; 2006 Apr; 22(1):40-9. PubMed ID: 16289867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis.
    Glas M; Popp B; Angele B; Koedel U; Chahli C; Schmalix WA; Anneser JM; Pfister HW; Lorenzl S
    Exp Neurol; 2007 Oct; 207(2):350-6. PubMed ID: 17716658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.
    Rembach A; Turner BJ; Bruce S; Cheah IK; Scott RL; Lopes EC; Zagami CJ; Beart PM; Cheung NS; Langford SJ; Cheema SS
    J Neurosci Res; 2004 Aug; 77(4):573-82. PubMed ID: 15264227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
    Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.